Technical analysis · daily indicators as of Nov 13, 2026
14.20
-0.71 (-4.76%)
Price chart
Drag to measure a move, wheel or pinch to zoom
The verdict
The main signals
Snapshot
A mixed picture: no side stands out.
Valueno data
– P/E below its industry's
– P/E below the market's
✗ Price to book below its industry's
– Price to sales below its industry's
– P/E below its profit growth rate (PEG under 1)
Past performanceno data
– Profit grew over the last 12 months
– Profit grew over 5 years
– Last year's profit growth beat its 5-year average
– Return on equity 20% or more
– Revenue grew over the last 12 months
Financial healthno data
– Profitable over the last 12 months
✓ Shareholders' equity is positive
– Debt below equity
– Debt below 40% of equity
– Cash covers debt
Dividendsno data
– Pays a dividend
– Yield above the lowest quarter of US dividend payers
– Yield in the top quarter of US dividend payers
– Dividend covered by earnings (payout under 90%)
– Yield above its industry's
Rewards
None found in our checks.
Risks
Price moves more than 90% of large US stocks
Each side counts 5 checks on the latest SEC results and today's price (tap a side for the checks). It describes the numbers; it is not a recommendation.
Fundamentals
Market cap
$1.6 B
Earnings (last 12 months)
–
Revenue (last 12 months)
–
P/E ratio
–
Price to sales
–
Earnings per share
–
Revenue
–
Earnings
–
Gross margin
–
Net profit margin
–
Debt to equity
–
From SEC filings; last results for the period ended 30 Sept 2026.
Returns against the market
ADRX
Industry
S&P 500
7 days
+7.3%
-0.9%
+2.5%
1 year
-26.6%
-29.8%
+10.4%
Beat its industry (Pharmaceutical Preparations): -26.6% against -29.8% over the past year.
Trailed the S&P 500: -26.6% against +10.4% over the past year.
Industry: the middle (median) stock of the same SEC industry. Price returns, dividends not added back.
How much the price moves
ADRX: average daily range
11.7%
Its industry
8.2%
Large US stocks (middle)
3.4%
10% most volatile large stocks
8.2%
10% least volatile
2.1%
A very volatile share: bigger daily swings than 90% of large US stocks. Daily range = the average high-to-low move over 14 days.
Pivot points come from the last session's high, low and close: traders watch R1–R3 as resistance above and S1–S3 as support below. The moving averages and Supertrend often act as support or resistance too.
Fundamentals
Sales Net profit
Quarterly results ($ million)
Yearly results ($ million, financial years)
Shareholding
From the results and shareholding patterns the company filed with the SEC. Ratios use today's price and the last 12 months of results. Information only, not investment advice.
No company results are available here for this stock yet.
Mutual funds holding ADARx Pharmaceuticals, Inc.
P/E against its own history
P/E each weekUsual levelWeeks at each levelNow
Weekly closing price ÷ profit a share from the company's results (last 4 quarters where filed, else the financial year; profit over today's share count, so bonus issues and splits do not distort it). Weeks with a loss are left out. A low P/E can mean cheap, or that the market expects profits to fall.